Skip to content
← Acute Myeloid Leukemia

FOR PATIENTS · SOURCE READING

Targeted therapy

Source: Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 16, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment Option Overview / The following types of treatment are used:

Targeted therapy uses drugs or other substances to identify and attack specific cancer cells. Your doctor may suggest biomarker tests to help predict your response to certain targeted therapy drugs. Learn more about Biomarker Testing for Cancer Treatment.

Source links and citations

Targeted therapies used to treat AML include:

gemtuzumab ozogamicin

Source links and citations

midostaurin

Source links and citations

quizartinib

Source links and citations

revumenib

Source links and citations

Less-intensive targeted therapies in people who are unable or unwilling to receive other treatments include:

enasidenib

Source links and citations

gilteritinib

Source links and citations

glasdegib

Source links and citations

ivosidenib

Source links and citations

venetoclax

Source links and citations

Learn more about Targeted Therapy to Treat Cancer.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice